Diabetic Patients Living in Warmers Climates Are More at Risk to Contract Fournier's Gangrene

Diabetes Drug Infection Lawsuit News

More and more cases of flesh-eating diseases are reported around the US particularly in the warmer southern states

Thursday, June 13, 2019 - The CDC has determined that diabetic patients that are taking SGLT2 blocker medications are at risk for Fournier's Gangrene, a type of necrotizing fasciitis. Fournier's gangrene is a variation of the common Streptococcus bacteria that most of us have come in contact with during bouts of "Strep throat." Fournier's medical signature is that the flesh-eating bacteria attack the genitals, starting in the perineum (the area between the anus and the scrotum or vulva), and the treatment usually requires genital amputation or surgical mutilation in order to attempt to stop the rapidly-spreading bacteria from engulfing and destroying the body's major organs. Only around 55 cases of Fournier's have been identified in the US over the last decade or so. There could be many more times that many, however, that are mistaken for a more common form of necrotizing fasciitis. According to Wikipedia, "Fournier gangrene is a type of necrotizing fasciitis or flesh-eating bacteria affecting the external genitalia and/or perineum. It commonly occurs in older men, but it can also occur in women and children. It is more likely to occur in diabetics, alcoholics, or those who are immunocompromised." Diabetes drug infection lawsuit handled by top national attorneys helping families and individuals harmed from diabetes drugs offer a free consultation and no obligation.

This week brings several more reports of necrotizing fasciitis or "flesh-eating" to communities on or around the warm water areas of the Gulf of Mexico, a body of water experts fear is a breeding ground for the hideous disease. 42-year old Adam Perez, currently homeless, is in danger of losing his leg after dipping his foot in the water near Water's Edge Park in Corpus Christi, Texas. Anti-biotic treatments to date have been ineffective and Perez has had to endure four surgeries to have most of the skin on his right leg below the knee surgically removed. If the spread of the disease is successfully halted, a series of skin grafts will be required, or the leg may have to be amputated. Doctors think that the flesh-eating bacteria entered the man through a crack in the skin under his big toenail that was infected with fungus.

The CDC has identified the patient's flesh-eating bacteria as "Vibrio," and have confirmed the fears of many that the bacteria may breed in the warmer climates putting the people that live, work, and play there and are in less than optimal health at risk. My San Antonio.com reported: "According to the CDC, about 80,000 people are infected with vibriosis, which is caused by the Vibrio bacteria. The bacteria live in coastal waters and increase concentration when the water warms between May and October. People typically become infected by consuming undercooked or raw seafood or exposing an open wound to seawater. "People with compromised immune systems, especially those with chronic liver disease, are more likely to get vibriosis. Eating raw seafood, particularly oysters, and exposing open wounds to saltwater or brackish water can increase a person's chance for getting vibriosis," according to the CDC.

In another related case of the flesh-eating disease, details are emerging of a 31-year old man that died in July 2018 from the flesh-eating disease after the bacteria presumably entered his body via a freshly inked tattoo on his calf muscle. Over the course of several weeks, the disease resisted antibiotics and spread deep throughout his leg requiring amputation and eventually leading to his death.

More Recent Diabetes Drug Infection Lawsuit News:

Lawyers for Fournier's Gangrene

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.